NCT06183047已完成不适用
Predictive Value of Early Changes of Chromogranin A Levels in Patients With Neuroendocrine Tumours Treated With PRRT
Military Institute od Medicine National Research Institute0 个研究点目标入组 38 人开始时间: 2016年10月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 38
- 主要终点
- The CgA level change
研究概览
简要总结
The results of the study suggest that an early change in CgA levels might serve as a prognostic factor in NET patients treated with PRRT.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •confirmed NET
- •peptide receptor radionuclide therapy (PRRT)
排除标准
- •lack of patient consent to a clinical trial
结局指标
主要结局
The CgA level change
时间窗: 2016-2023
We aimed to assess the predictive value of early release of chromogranin A (CgA) in patients with neuroendocrine tumours (NET) treated with peptide receptor radionuclide therapy (PRRT).
次要结局
未报告次要终点
研究者
相似试验
进行中（未招募）
不适用
Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following RadiotherapyProstate CancerNCT03017794Mayo Clinic118
Unknown
不适用
Next Day Growth Hormone Predicting Pituitary Function After AdenomectomyHypopituitarismNCT03708523National Taiwan University Hospital400
Unknown
4 期
Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine TumorsNon Functioning Pancreatic Endocrine TumorNCT02759718Asan Medical Center111
已完成
不适用
Investigation of the Effects of Diet on the Measurement of Plasma Chromogranin in NET PatientsNeuroendocrine TumorsNCT03288402University Hospitals Coventry and Warwickshire NHS Trust346
已完成
不适用
Evaluation of plasma Chromogranin A before and after treatment with various acid inhibitorsacid-related gastrointestinal diseasesJPRN-UMIN000019248Shimane University Faculty of Medicine300